Replication licensing and cancer--a fatal entanglement?
- PMID: 18756287
- PMCID: PMC2577763
- DOI: 10.1038/nrc2500
Replication licensing and cancer--a fatal entanglement?
Abstract
Correct regulation of the replication licensing system ensures that chromosomal DNA is precisely duplicated in each cell division cycle. Licensing proteins are inappropriately expressed at an early stage of tumorigenesis in a wide variety of cancers. Here we discuss evidence that misregulation of replication licensing is a consequence of oncogene-induced cell proliferation. This misregulation can cause either under- or over-replication of chromosomal DNA, and could explain the genetic instability commonly seen in cancer cells.
Figures
References
-
- Nishitani H, Lygerou Z. DNA replication licensing. Frontiers in Bioscience. 2004;9:2115–2132. - PubMed
-
- Arias EE, Walter JC. Strength in numbers: preventing rereplication via multiple mechanisms in eukaryotic cells. Genes Dev. 2007;21:497–518. - PubMed
-
- Labib K, Diffley JF. Is the MCM2-7 complex the eukaryotic DNA replication fork helicase? Curr Opin Genet Dev. 2001;11:64–70. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
